Cargando…

Vaccine-associated measles in a patient treated with natalizumab: a case report

BACKGROUND: Safety of live vaccines in patients treated with immunosuppressive therapies is not well known, resulting in contradictory vaccination recommendations. We describe here the first case of vaccine-associated measles in a patient on natalizumab treatment. CASE PRESENTATION: A young female p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miauton, Alix, Tan, Rainer, Pantazou, Vasiliki, Du Pasquier, Renaud, Genton, Blaise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556935/ https://www.ncbi.nlm.nih.gov/pubmed/33054715 http://dx.doi.org/10.1186/s12879-020-05475-9

Ejemplares similares

Natalizumab may control immune checkpoint inhibitor–induced limbic encephalitis
por: Hottinger, Andreas F., et al.
Publicado: (2018)

Natalizumab: COVID-19 infection: case report
Publicado: (2021)

Natalizumab: Progressive multifocal leukoencephalopathy: case report
Publicado: (2021)

Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab
por: Law, Jennie Y, et al.
Publicado: (2015)

Natalizumab: Pneumonia caused by COVID-19: case report
Publicado: (2020)

Natalizumab: COVID-19 infection: 19 case reports
Publicado: (2022)

Natalizumab: Pneumonitis and peripheral blood eosinophilia: case report
Publicado: (2022)

Fatal COVID-19 in an MS patient on natalizumab: A case report
por: Rimmer, Kathryn, et al.
Publicado: (2020)

Interferon-beta-1a/natalizumab: Lack of efficacy: case report
Publicado: (2021)

Natalizumab: Coronavirus disease-2019 infection: 6 case reports
Publicado: (2022)

Alemtuzumab/natalizumab/ocrelizumab: COVID-19: 3 case reports
Publicado: (2021)

Antigen rapid tests, nasopharyngeal PCR and saliva PCR to detect SARS-CoV-2: A prospective comparative clinical trial
por: Schwob, Jean-Marc, et al.
Publicado: (2023)

Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab
por: Lee, De-Hyung, et al.
Publicado: (2013)

The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing
por: van Kempen, Zoé LE, et al.
Publicado: (2017)

Ocrelizumab Impairs the Phenotype and Function of Memory CD8(+) T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis
por: Mathias, Amandine, et al.
Publicado: (2023)

Natalizumab-induced thrombocytopenia: A case report
por: Azimi, Amirreza, et al.
Publicado: (2022)

Necrotizing fasciitis following measles vaccine administration: a case report
por: Isere, E. E., et al.
Publicado: (2019)

Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report
por: Sotgiu, Stefano, et al.
Publicado: (2010)

Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report
por: Lee, De-Hyung, et al.
Publicado: (2014)

Alemtuzumab/cladribine/natalizumab: Lymphopenia and COVID-19 infection: case report
Publicado: (2021)

Glioblastoma in natalizumab‐treated multiple sclerosis patients
por: Sierra Morales, Fabian, et al.
Publicado: (2017)

Measles in a measles-eliminated country: A case report of a measles-infected postpartum mother and infant in Japan
por: Mito, Haruki, et al.
Publicado: (2021)

COVID-19 Vaccination Program for Undocumented Migrants: Notes from the Field of a Regional Center of General Medicine and Public Health, Canton of Vaud, Switzerland
por: Morisod, Kevin, et al.
Publicado: (2023)

Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
por: Gatzonis, Stylianos, et al.
Publicado: (2009)

Local public health response to vaccine-associated measles: case report
por: Hau, Monica, et al.
Publicado: (2013)

Measles-mumps-and-rubella-virus-vaccine: Aseptic meningitis: case report
Publicado: (2021)

Measles mumps and rubella virus vaccine: Various toxicities: case report
Publicado: (2022)

Pulmonary eosinophilia associated to treatment with natalizumab
por: Curto, Elena, et al.
Publicado: (2016)

Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018
por: Thar, Aye Mya Chan, et al.
Publicado: (2020)

Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis
por: Herold, Tina Rike, et al.
Publicado: (2012)

A Case of Drug-Induced Liver Injury Secondary to Natalizumab
por: Santoiemma, Phillip P., et al.
Publicado: (2020)

Acute retinal necrosis caused by co-infection with multiple viruses in a natalizumab-treated patient: a case report and brief review of literature
por: Cheraqpour, Kasra, et al.
Publicado: (2021)

Cognitive evolution in natalizumab-treated multiple sclerosis patients
por: Jacques, Francois H, et al.
Publicado: (2016)

Improvement of Comorbid Psoriasis in Patients With MS Treated With Natalizumab
por: Berkovich, Regina, et al.
Publicado: (2021)

Measles, mumps, and rubella vaccine in genital warts: A case report of two patients
por: Meena, Dilip, et al.
Publicado: (2018)

Measles hepatitis in a vaccinated liver transplant recipient: case report and review of literature
por: Mohiuddin, Syed Adnan, et al.
Publicado: (2017)

Immune Reconstitution Inflammatory Syndrome Mimicking Progressive Multifocal Leucoencephalopathy in a Multiple Sclerosis Patient Treated With Natalizumab: A Case Report and Review of the Literature
por: Evangelopoulos, Maria-Eleptheria, et al.
Publicado: (2015)

Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review
por: Yasuda, Yuichiro, et al.
Publicado: (2019)

Vaccine‐associated measles in an immunocompetent child
por: Sood, Shawn B., et al.
Publicado: (2017)

Response to “Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing”
por: van Kempen, Zoé LE, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3tr9p8umgpb3tha6e9pkjfrj7i